Cipla will launch ViraGen test kit in the country in partnership with Ubio Biotechnology Systems, the company stated.
The company will commence supply of the Covid-19 virus detection kit from May 25, 2021.
Umang Vohra, MD and Global CEO, Cipla, said, “Cipla has been working relentlessly to ensure accessibility to treatments in this fight against Covid-19. Guided by our core purpose of ‘Caring for Life’, this partnership will enable us to reach out to more people across the country at a crucial time like now.”
ViraGen is Cipla’s third offering in the Covid-19 testing segment.